Table 1 Clinical and perioperative characteristics of Non-IBD and IBD patients (n = 233)
Non-IBD (n = 199) | IBD (n = 34) | p-value | Total (n = 233) | |
|---|---|---|---|---|
Demographics | ||||
Sex, n (%) | .926 | |||
Male | 133 (66.8) | 23 (67.6) | 156 (67.0) | |
Female | 66 (33.2) | 11 (32.4) | 77 (33.0) | |
Age (years) | 59.5 ± 13.5 | 61.9 ± 13.1 | .507 | 59.9 ± 13.5 |
BMI (kg/m2) | 29.0 ± 5.9 | 27.0 ± 5.5 | .043 | 28.7 ± 5.8 |
ASA, n (%) | .760 | |||
I | 2 (1.0) | 0 (0) | 2 (0.0) | |
II | 119 (59.8) | 22 (64.7) | 141 (60.5) | |
III | 74 (37.2) | 12 (35.3) | 86 (36.9) | |
IV | 4 (2.0) | 0 (0) | 4 (1.7) | |
V | 0 (0) | 0 (0) | 0 (0) | |
CRD, n (%) | 16 (8) | 7 (20.6) | .054 | 23 (9.9) |
DM, n (%) | 40 (20.1) | 2 (5.9) | .053 | 42 (18.0) |
CVD, n (%) | 31 (15.6) | 10 (29.4) | .084 | 41 (17.6) |
CKD, n (%) | 27 (13.6) | 3 (8.8) | .445 | 30 (12.9) |
History of malignancy, n (%) | 49 (24.6) | 6 (17.6) | .376 | 55 (23.6) |
Perioperative data | ||||
Intraoperative blood transfusion, n(%) | 1 (0.5) | 3 (8.8) | .001 | 4 (1.7) |
ICU-stay, n(%) | 24 (12.1) | 8 (23.5) | .073 | 32 (13.7) |
Postoperative complications, n (%) | .004 | |||
No complications | 141 (70.9) | 18 (56.3) | 159 (68.8) | |
Clavien-Dindo I | 5 (2.5) | 2 (6.3) | 7 (3.0) | |
Clavien-Dindo II | 11 (5.5) | 1 (3.1) | 12 (5.2) | |
Clavien-Dindo IIIa | 31 (15.6) | 4 (12.5) | 35 (15.2) | |
Clavien-Dindo IIIb | 8 (4.0) | 6 (18.8) | 14 (6.1) | |
Clavien-Dindo IVa | 0 (0) | 1 (3.1) | 1 (0.4) | |
Clavien-Dindo IVb | 0 (0) | 0 (0) | 0 (0) | |
Clavien-Dindo V | 3 (1.5) | 0 (0) | 3 (1.3) | |
≥ Clavien-Dindo I | 58 (29.1) | 14 (41.2) | .161 | 72 (30.9) |
≥ Clavien-Dindo IIIb | 11 (5.5) | 7 (20.6) | .002 | 18 (7.7) |
SSI | 12 (6.0) | 5 (14.7) | .072 | 17 (7.3) |
Seroma | 33 (16.7) | 9 (26.5) | .166 | 42 (18.0) |
Relaparotomy | 7 (3.5) | 5 (14.7) | .006 | 12 (5.2) |